Literature DB >> 2024659

Prostatic involvement in Wegener's granulomatosis.

V J Bray1, J A Hasbargen.   

Abstract

Two cases of Wegener's granulomatosis presenting with prostatic involvement are described and compiled with the five previously detailed cases. Each of these patients presented with obstructive symptoms, proteinuria, leukocyturia, and hematuria. The urinary sediment normalized with treatment of the underlying granulomatous vasculitis. Wegener's granulomatosis is a rare cause of prostatic obstructive symptoms, but should be considered whenever the relatively unusual entity of granulomatous prostatitis is diagnosed. One patient was initially treated exclusively with trimethoprim-sulfamethoxazole (TMP-SMX). He responded, but noted recurrence during the 15th month of treatment. We also report on this patient's antineutrophil cytoplasmic antibody (ANCA) titers, which correlated with clinical assessment and predicted recurrence 2 months before elevation of the Westergren sedimentation rate (WSR) and clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024659     DOI: 10.1016/s0272-6386(12)80500-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Wegener's granulomatosis diagnosed by testicular biopsy.

Authors:  Mahendra Agraharkar; Sumita Gokhale; Rajiv Gupta
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Prostate involvement in granulomatosis with polyangiitis.

Authors:  Roman Yatsyshyn; Olena Zimba; Mykola Bahrii; Bohdana Doskaliuk; Vitalii Huryk
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

3.  Wegener's granulomatosis of the prostate gland.

Authors:  Ragnar Gunnarsson; Roald Omdal; Kjell H Kjellevold; Christian L Ellingsen
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

4.  Anti-MPO small-vessel vasculitis causing prostatis and nephritis.

Authors:  Jorge A Lamarche; Alfredo M Peguero; Joaquin O Rosario; Amit Patel; Craig Courville
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.